Dr. Ahmad Shaker
Claim this profileSaint Anthony's Hospital Cancer Care Center
Studies Colorectal Cancer
Studies Lung Cancer
4 reported clinical trials
12 drugs studied
Area of expertise
1Colorectal Cancer
dMMR negative
MSI-H negative
Stage IV
2Lung Cancer
Stage III
Stage II
PD-L1 negative
Affiliated Hospitals
Clinical Trials Ahmad Shaker is currently running
IPH5201 + Durvalumab + Chemotherapy
for Lung Cancer
The study is intended to assess the safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab in untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC).
Recruiting1 award Phase 211 criteria
Irinotecan + FOLFOX Chemotherapy
for Rectal Cancer
This trial is testing different treatments in patients with advanced rectal cancer to see which one is more effective at shrinking the tumor or stopping its growth, potentially avoiding surgery.
Recruiting1 award Phase 2
More about Ahmad Shaker
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ahmad Shaker has experience with
- Irinotecan
- Durvalumab
- IPH5201
- Standard Chemotherapy
- Leucovorin Calcium
- Fluorouracil
Breakdown of trials Ahmad Shaker has run
Colorectal Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ahmad Shaker specialize in?
Ahmad Shaker focuses on Colorectal Cancer and Lung Cancer. In particular, much of their work with Colorectal Cancer has involved dMMR negative patients, or patients who are MSI-H negative.
Is Ahmad Shaker currently recruiting for clinical trials?
Yes, Ahmad Shaker is currently recruiting for 3 clinical trials in Saint Petersburg Florida. If you're interested in participating, you should apply.
Are there any treatments that Ahmad Shaker has studied deeply?
Yes, Ahmad Shaker has studied treatments such as Irinotecan, Durvalumab, IPH5201.
What is the best way to schedule an appointment with Ahmad Shaker?
Apply for one of the trials that Ahmad Shaker is conducting.
What is the office address of Ahmad Shaker?
The office of Ahmad Shaker is located at: Saint Anthony's Hospital Cancer Care Center, Saint Petersburg, Florida 33705 United States. This is the address for their practice at the Saint Anthony's Hospital Cancer Care Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.